摘要
目的:观察阿托伐他汀对实验性自身免疫性脑脊髓炎(experimental autoimmune encephalomyelitis,EAE)Wistar大鼠的发病情况、组织病理变化及脑组织内T细胞免疫球蛋白和黏液域蛋白-3(TIM-3)、T细胞免疫球蛋白和黏液域蛋白-1(TIM-1)表达水平的影响。方法:将30只雌性Wistar大鼠随机分为佐剂组、EAE组、阿托伐他汀组,以豚鼠脊髓匀浆(GPSCH)诱发制备大鼠EAE模型,并于给予GPSCH当日开始1次/d灌服0.1%PBS溶液1.5ml/只(佐剂组和EAE组)和含阿托伐他汀的0.1%PBS溶液,1次/d,剂量为8mg/(kg·d),连续13d,观察EAE症状并评分,用逆转录-聚合酶链反应(RT-PCR)法检测Tim-1mRNA、Tim-3mRNA在脑组织中的表达。结果:阿托伐他汀组发病率降低、临床症状减轻,体重下降减少(P<0.05);与佐剂组比较,EAE组TIM-3mRNA明显上升(P<0.05),阿托伐他汀组TIM-3mRNA较EAE组明显下降(P<0.05);与佐剂组比较,EAE组TIM-1mRNA下降(P<0.05),阿托伐他汀组TIM-1mRNA较EAE组上升(P<0.05)。结论:EAE大鼠TIM-3上升,TIM-1下降,提示其在EAE发病机制中发挥作用,通过下调TIM-3、上调TIM-1的表达,可能是阿托伐他汀对EAE保护作用机制之一。
Objective:To observe atorvastatin on experimental autoimmune encephalomyelitis(Experimental Autoimmune Encephalomyelitis,EAE),the incidence of Wistar rats,histopathological changes and brain tissue T cell immunoglobulin and mucus domain protein-3(the TIM-3) T-cell immune globulin and mucus-domain protein-1(TIM-1) expression levels.Method:30 female Wistar rats were randomly divided into three groups:the adjuvant group,EAE group,and atorvastatin statin group.The preparation of guinea pig spinal cord homogenate(GPSCH) induced rat EAE model,and give GPSCH at the beginning of the day once daily gavage 0.1% PBS solution 1.5 ml(adjuvant group and EAE group) containing atorvastatin 0.1% PBS solution,once a day.Dose of 8 mg/(kgod),for 13 consecutive days to observe the EAE symptoms and rate,using reverse transcription-polymerase chain reaction(RT-PCR) assay the expression of Tim-1 mRNA in Tim-3 mRNA in the brain tissue.Result:Atorvastatin atorvastatin group decreased incidence,clinical symptoms,reduced weight loss(P0.05).The comparison with adjuvant group,EAE group the TIM-3 mRNA increased(P0.05),atorvastatin the statin group the TIM-3 mRNA compared EAE group decreased(P0.05).The comparison with adjuvant group,EAE group the TIM-1 mRNA decreased(P0.05),atorvastatin the statin group the TIM-1 mRNA increased compared with the EAE group,and a statistically significant(P0.05).Conclusion:TIM-3 increased and TIM-1 decreased in EAE rats,which suggests that atorvastatin plays a role in EAE pathogenesis.This may be a protection mechanism of atorvastatin for EAE.
出处
《中国医学创新》
CAS
2012年第36期14-17,共4页
Medical Innovation of China